Keyword search
Filter results by
Search HelpKeyword(s)
Year of publication
Geography
Survey or statistical program
- Vital Statistics - Death Database (17)
- Canadian Cancer Registry (15)
- Canadian Health Measures Survey (12)
- Canadian Community Health Survey - Annual Component (4)
- Canadian COVID-19 Antibody and Health Survey (CCAHS) (3)
- COVID-19 epidemiological reports (2)
- Canadian Survey on Disability (1)
- Census of Population (1)
- Longitudinal Immigration Database (1)
- Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (1)
- Life After Service Survey (1)
- Impacts of COVID-19 on Canadians: Data Collection Series (1)
- Survey on Accessibility in Federal Sector Organizations (SAFSO) (1)
Portal
Results
All (63)
All (63) (0 to 10 of 63 results)
- Table: 13-10-0111-01Geography: Canada, Province or territoryFrequency: AnnualDescription:
Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.
Release date: 2026-02-27 - Table: 13-10-0747-01Geography: Canada, Province or territoryFrequency: AnnualDescription:
The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.
Release date: 2026-02-27 - Table: 13-10-0141-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0142-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0144-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0145-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the nervous system, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0146-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the eye and adnexa, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0147-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the circulatory system, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0148-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the digestive system, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0149-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the skin and subcutaneous tissue, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
Data (33)
Data (33) (0 to 10 of 33 results)
- Table: 13-10-0111-01Geography: Canada, Province or territoryFrequency: AnnualDescription:
Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.
Release date: 2026-02-27 - Table: 13-10-0747-01Geography: Canada, Province or territoryFrequency: AnnualDescription:
The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.
Release date: 2026-02-27 - Table: 13-10-0141-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0142-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0144-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0145-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the nervous system, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0146-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the eye and adnexa, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0147-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the circulatory system, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0148-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the digestive system, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
- Table: 13-10-0149-01Geography: CanadaFrequency: AnnualDescription: Number of deaths caused by diseases of the skin and subcutaneous tissue, by age group and sex, 2000 to most recent year.Release date: 2026-01-13
Analysis (30)
Analysis (30) (0 to 10 of 30 results)
- Articles and reports: 82-625-X202500100002Description: This fact sheet provides an overview of proportions of Canadians who have undergone tests commonly used for early detection of colorectal, cervical and breast cancer among people living in the ten provinces. It also examines differences by various groups, such as by sex, age, province, area type, racialized group, immigrant status, Indigenous group and disability status.Release date: 2025-08-06
- Articles and reports: 82-003-X202500600001Description: The OncoSim-Breast model, developed by the Canadian Partnership Against Cancer and Statistics Canada, represents breast cancer-related events in the Canadian female population. This study aims to compare OncoSim-Breast microsimulation modelling results with recent results from the United States’ National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. The primary focus is on the impact of extending breast cancer screening to women aged 40 to 49.Release date: 2025-06-18
- Articles and reports: 82-003-X202401200002Description: After six cycles of using the BpTRU (BT) BPM-300 blood pressure (BP) monitor, the Canadian Health Measures Survey (CHMS) introduced the OMRON (OM) IntelliSense HEM-907XL BP monitor in Cycle 7. This study assesses differences between BP values measured by both devices in children and youth aged 6 to 17 years and whether equations could be developed to compare BP measurements taken using the two devices.Release date: 2024-12-18
- Articles and reports: 82-003-X202401100001Description: Managing breast cancer involves a range of health care settings and has considerable implications on health care resources. While studies have looked at breast cancer costs in Canada by subtype and stage, there is a gap in understanding breast cancer costs related to phase of care and disease stage. This study assessed health care system costs and resource utilization for adult women with breast cancer in Ontario, Canada. The goal was to update costs by stage, age, and phase of care from a health care system perspective.Release date: 2024-11-20
- Stats in brief: 11-627-M2024050Description: Utilizing data from the 2022 Canadian Survey on Disability, this infographic highlights the trends and experiences of persons with pain-related disabilities. This release is part of a series of infographics that focus on specific disability types.Release date: 2024-11-06
- Articles and reports: 82-003-X202401000001Description: In Cycle 7 (2022), the Canadian Health Measures Survey (CHMS) introduced the OMRON (OM) IntelliSense HEM-907XL blood pressure (BP) monitor after using the BpTRU (BT) BPM-300 BP monitor for six cycles. This study assess differences between adult BP values measured by both devices and whether equations could be developed to compare BP measurements taken using the two devices.Release date: 2024-10-16
- Articles and reports: 82-003-X202300600002Description: Traumatic brain injuries (TBIs) are a major public health concern impacting the lives of many Canadians. Among all TBIs, concussions are the most common. However, to date, the incidence of concussions among the Canadian population has remained unknown. To address this data surveillance gap, this study presents national estimates on the percentage of Canadians aged 12 years or older (excluding those living in the territories) who sustained one or more concussions in 2019.Release date: 2023-06-21
- Articles and reports: 82-003-X202300500001Description: Research has identified an association between sleep and obesity in the general population, it is also important to examine this association in the military population. This study presents the prevalence of overweight, obesity, sleep duration and measures of sleep quality in the Canadian Armed Forces. In addition, the independent associations of sleep duration and sleep quality with obesity are examined.Release date: 2023-05-17
- Articles and reports: 82-003-X202300400001Description: To date, population estimates of hypertension prevalence among children and adolescents in Canada have been based on clinical guidelines in the National High Blood Pressure Education Program’s 2004 Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents (NHBPEP 2004). In 2017, the American Academy of Pediatrics published updated guidelines in Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents (AAP 2017), followed by Hypertension Canada in 2020 with its publication of Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children (HC 2020). This is the first study in Canada to compare the national estimates of the prevalence of child and adolescent hypertension based on AAP 2017 with estimates of prevalence based on NHBPEP 2004 and HC 2020. The main objectives of this analysis were to apply AAP 2017 and HC 2020 to all six cycles of Canadian Health Measures Survey data available to date and examine the effect on population estimates of hypertension prevalence by sex and age group among children and adolescents aged 6 to 17. This study also examines the impact of applying AAP 2017 across time and selected characteristics, describes those who are reclassified into a higher BP category under AAP 2017, and examines differences in hypertension prevalence resulting from applying HC 2020 versus AAP 2017.Release date: 2023-04-19
- Articles and reports: 82-003-X202300300002Description: Previous studies examining the cardiometabolic risks associated with physical activity (PA) in workers have predominantly used self-reported measures. Little is known about workers’ distinct daily PA patterns and whether these are linked with cardiometabolic risks. This study examined associations between patterns of workers’ accelerometer-measured daily PA and four markers of cardiometabolic health. Furthermore, the study examined similarities and differences between younger compared to middle-aged and older workers, and between men and women, to understand whether these groups are associated with different cardiometabolic risks.Release date: 2023-03-15
Reference (0)
Reference (0) (0 results)
No content available at this time.